FDA
-
-
-
-
-
-
-
Gain Therapeutics reports interim data from Parkinson's disease study
-
-
-
-
-
-
-
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
-
-
-
-
-
-
-
Gain Therapeutics reports brain target engagement in Parkinson's study
-
-
-
-
-
-
-
Gain Therapeutics reports early data from Parkinson's drug trial
-
-
-
-
-
-
-
Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update
-
-
-
-
-
-
-
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
-
-
-
-
-
-
-
Gain Therapeutics (GANX) Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
-
326,546 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

